6533b821fe1ef96bd127ba08

RESEARCH PRODUCT

Melatonin Treatment Alters Biological and Immunomodulatory Properties of Human Dental Pulp Mesenchymal Stem Cells via Augmented Transforming Growth Factor Beta Secretion.

Francisco Javier Rodríguez-lozanoEsther M. García-navarroJosé M. MoraledaLeopoldo FornerSergio López-garcíaJosé Luis SanzDavid García-bernalJulia Guerrero-gironés

subject

0301 basic medicineEndogenyPharmacologyMelatonin03 medical and health sciences0302 clinical medicineOsteogenesisTransforming Growth Factor betaDental pulp stem cellsmedicineHumansViability assayTransforming growth factor-beta secretionGeneral DentistryCells CulturedDental PulpCell ProliferationMelatoninbiologyChemistryStem CellsMesenchymal stem cellCell migrationCell DifferentiationMesenchymal Stem Cells030206 dentistryTransforming growth factor beta030104 developmental biologybiology.proteinhormones hormone substitutes and hormone antagonistsmedicine.drug

description

Melatonin is an endogenous neurohormone with well-reported anti-inflammatory and antioxidant properties, but the direct biological and immunomodulatory effects of melatonin on human dental pulp stem cells (hDPSCs) has not been fully elucidated. The aim of this study was to evaluate the influence of melatonin on the cytocompatibility, proliferation, cell migration, odontogenic differentiation, mineralized nodule formation, and immunomodulatory properties of hDPSCs.To address the melatonin biological effects on hDPSCs, the cytocompatibility, proliferation, cell migration, odontogenic differentiation, mineralized nodule formation, and immunomodulatory properties of hDPSCs after melatonin treatment were evaluated. The statistical differences were evaluated using 1-way analysis of variance with the Tukey multiple comparison test.We found that melatonin did not alter hDPSC immunophenotype or cell viability, even at the highest concentrations used. However, using intermediate melatonin concentrations (10-300 μmol/L), a significantly higher proliferation rate (P.05 and P.01) and migration of hDPSCs (P.01) were observed. Importantly, melatonin treatment (100 μmol/L) significantly increased the secretion of the anti-inflammatory cytokine transforming growth factor beta (P.05 and P.01) and provoked a more robust antiproliferative effect on mitogen-stimulated T cells (P.05). Finally, and unlike previous results found with mesenchymal stem cells from other sources, melatonin fails to induce or accelerate the spontaneous osteogenic differentiation of hDPSCs.Together, these findings provide key data on the bioactivity of melatonin and its effects on hPDSC biological and immunomodulatory properties.

10.1016/j.joen.2020.12.008https://pubmed.ncbi.nlm.nih.gov/33359532